Randomized controlled trials do not reflect reality: Real-world analyses are critical for treatment guidelines!

Journal of Thoracic and Cardiovascular Surgery

Volumn 132, Issue 1, 2006, Pages 5-7

  Grapow, Martin T R ^a   von Wattenwyl, Robert ^a   Guller, Ulrich ^a   Beyersdorf, Friedhelm ^b   Zerkowski, Hans Reinhard ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; DECISION MAKING; DRUG ELUTING STENT; EDITORIAL; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; ISCHEMIC HEART DISEASE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PHYSICIAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; REVASCULARIZATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

CORONARY ARTERY BYPASS; HUMANS; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PRACTICE GUIDELINES; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN;

EID: 33745203549     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2006.03.035     Document Type: Editorial

References (14)

1. Hannan E.L., Racz M.J., Walford G., Jones R.H., Ryan T.J., Bennett E., et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med 352 (2005) 2174-2183
2. Loop F.D., Lytle B.W., Cosgrove D.M., Stewart R.W., Goormastic M., Williams G.W., et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med 314 (1986) 1-6
3. The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. N Engl J Med 311 (1984) 1333-1339
4. Bruckenberger E. In: Bruckenberger E. (Ed). Herzbericht 2003 mit Transplantationschirurgie. 16th ed. (2004), Hannover
5. Freiman J.A., Chalmers T.C., Smith Jr. H., and Kuebler R.R. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. N Engl J Med 299 (1978) 690-694
6. Guller U., and Oertli D. Sample size matters. a guide for surgeons. World J Surg 29 (2005) 601-605
7. Brett W., Hirschmann M.T., Guller U., and Zerkowski H.-R. CABG vs. PCI in coronary artery disease: what is the evidence?. Card Surg Today 2 (2005) 43-55
8. Hoffman S.N., TenBrook J.A., Wolf M.P., Pauker S.G., Salem D.N., and Wong J.B. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty. one- to eight-year outcomes. J Am Coll Cardiol 41 (2003) 1293-1304
9. Yusuf S., Zucker D., Peduzzi P., Fisher L.D., Takaro T., Kennedy J.W., et al. Effect of coronary artery bypass graft surgery on survival. overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 344 (1994) 563-570
10. Taggart D.P. Surgery is the best intervention for severe coronary artery disease. BMJ 330 (2005) 785-786
11. Brener S.J., Lytle B.W., Casserly I.P., Schneider J.P., Topol E.J., and Lauer M.S. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation 109 (2004) 2290-2295
12. Adamina M., Guller U., Weber W.P., and Oertli D. Propensity score and the surgeon. Br J Surg (2006) Epub ahead of print
13. Guller U. Surgical outcomes research based on administrative data. inferior or complementary to prospective randomized clinical trials?. World J Surg 30 (2006) 255-266
14. van Domburg R.T., Lemos P.A., Takkenberg J.J., Liu T.K., van Herwerden L.A., Arampatzis C.A., et al. The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease. Eur Heart J 26 (2005) 675-681